Evidence map›Paper›PMID 41184490›Full record

ArticleNature biotechnology2026

Growth-coupled microbial biosynthesis of the animal pigment xanthommatin.

Leah B Bushin, Tobias B Alter, María V G Alván-Vargas, Lara Dürr, Elina C Olson, Mariah J Avila, Daniel C Volke, Òscar Puiggené, Taehwan Kim, Leila F Deravi and 3 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Systems metabolic engineering for hydroxytyrosol production inApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Leah B BushinCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-0538-2469
Tobias B AlterThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0002-9593-4388
María V G Alván-VargasThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Lara DürrCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA.
Elina C OlsonDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Mariah J AvilaCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-7050-400X
Daniel C VolkeThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0003-0244-2534
Òscar PuiggenéThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0001-7790-273X
Taehwan KimDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA.
Leila F DeraviDepartment of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3226-2470
Adam M FeistThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID http://orcid.org/0000-0002-8630-4800
Pablo I NikelThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark. pabnik@biosustain.dtu.dk.ORCID http://orcid.org/0000-0002-9313-7481
Bradley S MooreCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA. bsmoore@ucsd.edu.ORCID http://orcid.org/0000-0002-4652-1253

Funding

Natural Product Genome MiningR01GM085770 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R, MOORE, BRADLEY S · 2009 to 2024
$5.8M
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
Engineering bacteria for production and delivery of the halogenated prodrug lead L-4-chlorokynurenineF32GM149120 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BUSHIN, LEAH · 2023 to 2024
$146k
NIGMS NIH HHS F32 GM149120NIGMS NIH HHS R01 GM085770NIH HHS S10 OD026929Novo Nordisk NNF10CC1016517Novo Nordisk NNF18CC0033664Novo Nordisk NNF20CC0035580Novo Nordisk Fonden (Novo Nordisk Foundation) NNF10CC1016517Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 214366United States Department of Defense | United States Navy | Office of Naval Research (ONR) N000142412649U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32-GM149120U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-GM085770U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) F32-GM149120
6 · The paper itself

Abstract

Engineering heterologous natural product pathways in bacteria has achieved broad success but most approaches suffer from low initial production levels that require extensive, resource-heavy iterative strain optimization. Xanthommatin is a structurally complex, color-changing animal ommochrome with material and cosmetic applications, yet production in microbial cell factories has been difficult. Here, we introduce a growth-coupled biosynthetic strategy involving a feedback loop where an excised one-carbon (C1) moiety is used as a driver of bacterial growth, simultaneously boosting bioproduction of the target compound. This broadly applicable, plug-and-play strategy is illustrated by enabling xanthommatin biosynthesis in a 5,10-methylenetetrahydrofolate auxotroph of the platform soil bacterium Pseudomonas putida. In this design, formate released during xanthommatin production relieves the C1 deficiency, thereby effectively coupling bacterial growth to pigment synthesis. Adaptive laboratory evolution streamlined xanthommatin's gram-scale bioproduction from glucose, establishing C1 restoration as a general biosynthetic approach to accelerate the engineering of natural product biosynthesis in bacteria.

Indexed as

Metabolic EngineeringPigments, BiologicalPseudomonas putidaAnimalsPigments, Biological

Identifiers

PMID41184490
PMCPMC13571322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.